ISIN | LU0515381027 |
---|---|
Valor Number | 11923354 |
Bloomberg Global ID | BBG001746GZ1 |
Fund Name | CT (Lux) European Growth & Income A GBP |
Fund Provider |
Columbia Threadneedle Investments
Web: www.columbiathreadneedle.com Phone: +352 464 0107 460 E-Mail: Lux-CTenquiries@statestreet.com |
Fund Provider | Columbia Threadneedle Investments |
Representative in Switzerland |
Reyl & Cie S.A. Genève Phone: +41 22 816 80 00 |
Distributor(s) |
Banque Cantonale de Genève Genève 2 Phone: +41 22 317 27 27 |
Asset Class | Bonds |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Portfolio is to achieve long-term capital appreciation and an enhanced level of income by investing in companies listed on one of the European States Stock Exchanges or a regulated market. |
Peculiarities |
Current Price * | 28.53 GBP | 19.09.2024 |
---|---|---|
Previous Price * | 28.17 GBP | 18.09.2024 |
52 Week High * | 28.86 GBP | 30.08.2024 |
52 Week Low * | 22.88 GBP | 23.10.2023 |
NAV * | 28.53 GBP | 19.09.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 37,406,988 | |
Unit/Share Assets *** | 32,245,134 | |
Trading Information SIX |
YTD Performance | +11.14% |
29.12.2023 - 19.09.2024
29.12.2023 19.09.2024 |
---|---|---|
YTD Performance (in CHF) | +16.77% |
29.12.2023 - 19.09.2024
29.12.2023 19.09.2024 |
1 month | -0.56% |
19.08.2024 - 19.09.2024
19.08.2024 19.09.2024 |
3 months | +1.97% |
19.06.2024 - 19.09.2024
19.06.2024 19.09.2024 |
6 months | +6.22% |
19.03.2024 - 19.09.2024
19.03.2024 19.09.2024 |
1 year | +20.48% |
19.09.2023 - 19.09.2024
19.09.2023 19.09.2024 |
2 years | +38.29% |
20.09.2022 - 19.09.2024
20.09.2022 19.09.2024 |
3 years | +28.22% |
20.09.2021 - 19.09.2024
20.09.2021 19.09.2024 |
5 years | +53.72% |
19.09.2019 - 19.09.2024
19.09.2019 19.09.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk A/S Class B | 4.80% | |
---|---|---|
ASML Holding NV | 4.25% | |
Roche Holding AG | 3.34% | |
SAP SE | 3.33% | |
Intesa Sanpaolo | 3.26% | |
M&G PLC Ordinary Shares | 2.99% | |
AstraZeneca PLC | 2.93% | |
Phoenix Group Holdings PLC | 2.76% | |
SSE PLC | 2.73% | |
Deutsche Telekom AG | 2.63% | |
Last data update | 31.07.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 2.00% |
Ongoing Charges *** | 1.82% |
SRRI ***
|
|
SRRI date *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |